Nick McCooke

independent chairman
Pharmaceutical science
Biogazelle
Belgium

Business Expert Pharmaceutical Sciences
Biography

 Nick is an experienced and successful bio-entrepreneur, well-known for building and leading the Solexa team that pioneered Next Generation Sequencing (NGS), technology that became the basis of Illumina’s current market-leading product line. Apart from his base in the UK, Nick has lived and worked in the USA, Japan and Belgium. He acted as CEO of Pronota, interim COO of Cambridge Epigenetix, part-time CEO of Oxford Cancer Biomarkers and CEO of Solexa. Nick is currently CBO of DNA Electronics, a non-executive director of Bioventix PLC and a trustee of the Association of Medical Research Charities.

Research Intrest

 DNA sequencing by solexa method  cancer diagnosis

Global Scientific Words in Pharmaceutical Sciences